All posts tagged
Roche Abandons Spanish Cancer Epigenetics Drug
Roche and Ireland’s Biggest Biopharma take their Parkinson’s Antibody to Phase II
More News! Roche’s Stellar Hemophilia A Treatment & Two Big Rounds for Arix
What Happens when the Immune System Attacks Life-Saving Drugs?
More News! Shire wows with late-stage clinical results for its potential blockbuster
Roche’s Checkpoint Inhibitor Misfires in Late-Stage Trials
The Top 12 Biotech Leaders you should know in Basel
How is Biotech Transforming Pharma’s R&D Model?
Roche lands FDA Approval for the Best Multiple Sclerosis Drug Yet
Which European Blockbusters Topped the Charts in 2016?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
Labiotech UG, All Rights Reserved -
Send this to a friend